Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Small. 2020 Aug 18;16(38):e2002791. doi: 10.1002/smll.202002791

Figure 4.

Figure 4.

MTH-released tofacitinib inhibits BMDC activation. The indicated volume of MTH or gel alone was added via transwell inserts to the culture plates containing BMDCs followed by LPS. Cell activation was measured via (a) CD80, (b) CD86, and (c) MHCII expression levels.